5-Amino-1MQ

5-Amino-1MQ is a small-molecule NNMT inhibitor discussed for fat loss, body recomposition and energy. Community experiences range from subtle waist or stamina changes to no benefit and unpleasant effects; many involve dieting or other compounds. Human dose and timing claims remain uncertain.

A small molecule, not a peptide. 5-Amino-1MQ inhibits NNMT, an enzyme involved in processing nicotinamide and methyl groups. The NAD-related metabolism story explains the interest; it does not make this NAD+ replacement. Neelakantan et al. — selective NNMT inhibitors in obese mice (Animal context · Accessed 2026-09-30)

Capsules and injections have separate reports and amounts. Oral capsules/powder, subcutaneous products and occasional sublingual experiments appear in discussion. Iodide and chloride salt names also occur; the opened chloride thread does not establish that one salt works better. Looking for real-world experiences and data on 5-Amino-1MQ (Community discussion · Accessed 2026-09-30) · FDA — GenoGenix warning letter, January 20, 2026 (Official context · Accessed 2026-09-30)

Source context — Neelakantan et al. — selective NNMT inhibitors in obese mice: Cell/mouse evidence, not human outcomes. Mirror access; PMC CAPTCHA and PubMed open failed.

Source context — Looking for real-world experiences and data on 5-Amino-1MQ: Unverified products; route/dose frequency gaps, Reta/Tirz/SS-31/Glow co-use; no salt superiority test.

Source context — FDA — GenoGenix warning letter, January 20, 2026: Facility-specific 503B finding; no human efficacy assessment or universal legal conclusion.

A leaner-looking waist. Midsection and clothing-fit changes are sought during cuts, often alongside a calorie deficit and training. These impressions cannot prove targeted visceral-fat loss.

Feeling energized does not settle whether fat changed. PamelaF3211 reported alertness/endurance without fat loss; Naven71 felt nothing after 30 days. Two injection-update commenters noticed no difference around two weeks at 5 mg/day. Experience with 5-Amino-1MQ after a month (Personal report · Accessed 2026-09-30) · Injectable 5-Amino-1MQ Update! Day 3! (Personal report · Accessed 2026-09-30)

Appetite and muscle claims need perspective. Keeping muscle while losing fat is a community goal. Photos, clothing fit and feeling stronger do not prove preserved lean mass or reduced visceral fat. Appetite need not feel suppressed.

Source context — Experience with 5-Amino-1MQ after a month: Unverified products; diet/training and mixed routes. Thread includes seller promotion. The blend ratio basis is unstated.

Source context — Injectable 5-Amino-1MQ Update! Day 3!: OP contains an affiliate code and ephedrine/SLU-PP-332/MOTS-c co-use. Short follow-up; perceived route equivalence is not PK.

Oral: 50–150 mg/day is a circulating band. One month-log used 25 mg morning plus 25 mg early afternoon: 50 mg/day; 75 mg added no clear benefit. Separate charts describe 50 mg once, twice or three times daily. Reported amounts are not an escalation plan. Experience with 5-Amino-1MQ after a month (Personal report · Accessed 2026-09-30)

Other oral charts disagree. Preserved charts include 5–25 mg/day, a 75 mg/day middle claim, and 100–300 mg+/day. Talk near 400 mg/day comes from animal-to-human scaling, not demonstrated human need. A personal cardio-day example used 100 mg versus 50 mg on other days.

SC microgram charts: 150–600 mcg/day. A copied 12-week table lists 150, 300, 450 and 600 mcg/day in successive blocks; some charts use 450–500 mcg mid-block or AM/PM splits. These are circulated tables, with favorable and unchanged reports at low amounts. 5-Amino-1MQ guide. (Community guide · Accessed 2026-09-30) · 5-amino-1mq experiences (Community discussion · Accessed 2026-09-30)

No validated oral-to-injection conversion. Rat absorption percentages and subjective route comparisons cannot convert oral mg into human injected amounts. Injectable 5-Amino-1MQ Update! Day 3! (Personal report · Accessed 2026-09-30)

SC milligram reports are a separate set. Preserved claims include 2.5–5 mg/day, sometimes 2.5 mg twice daily, and charts of 10–30 mg/day. Theappache10 reported 500 mcg–1.5 mg SC with little energy and no fat-burning benefit; frequency was unstated. Looking for real-world experiences and data on 5-Amino-1MQ (Community discussion · Accessed 2026-09-30)

Source context — Experience with 5-Amino-1MQ after a month: Unverified products; diet/training and mixed routes. Thread includes seller promotion. The blend ratio basis is unstated.

Source context — 5-Amino-1MQ guide.: Guide combines community claims and rodent scaling. Prevalence, diminishing returns and promised timelines are unsupported. Recipes and purchasing links excluded.

Source context — 5-amino-1mq experiences: Route/frequency unclear for early microgram nonresponse; Reta co-use.

Source context — Injectable 5-Amino-1MQ Update! Day 3!: OP contains an affiliate code and ephedrine/SLU-PP-332/MOTS-c co-use. Short follow-up; perceived route equivalence is not PK.

Source context — Looking for real-world experiences and data on 5-Amino-1MQ: Unverified products; route/dose frequency gaps, Reta/Tirz/SS-31/Glow co-use; no salt superiority test.

Oral changes can be subtle or absent. The month-log reports no immediate stimulation, then waist impressions after 2–3 weeks while dieting/lifting. Other logs place visible change at 3–4 or 4–8 weeks; none supplies a predictable clock. Experience with 5-Amino-1MQ after a month (Personal report · Accessed 2026-09-30)

Injection sensations can arrive sooner than body changes. The women’s thread describes feeling amped/fluttery after injection; its OP amount is internally inconsistent. The three-day affiliate log describes early energy. Neither establishes minutes-to-benefit or fat loss after one administration. 5 amino 1mq experiment. (Community discussion · Accessed 2026-09-30) · Injectable 5-Amino-1MQ Update! Day 3! (Personal report · Accessed 2026-09-30)

A day-long energy report exists. m3z1824 described energy through the day during 22 days of 5 mg/day SC, with Reta and several other compounds. The same account describes roughly hour-long cramps; that is a symptom window, not drug clearance. 5 amino 1mq (Personal report · Accessed 2026-09-30)

No reliable single-dose or post-stop window. The discussions do not isolate hours of benefit or how long waist changes persist. Preserved post-stop accounts connect regain to diet/GLP-1 changes rather than demonstrating a unique rebound syndrome. Looking for real-world experiences and data on 5-Amino-1MQ (Community discussion · Accessed 2026-09-30)

About 8 hours injectable: an unsupported promotional claim. An affiliate Reddit table asserts this figure and a clearance window without human measurements. It stays a separate claim; no defensible human half-life emerges from the opened discussion. 5-Amino-1MQ — Full Breakdown (Secondhand community claim · Accessed 2026-09-30)

Rat measurements do not establish human kinetics. Awosemo’s abstract reports oral 6.90 ± 1.20 hours and IV 3.80 ± 1.10 hours, with 38.4% oral bioavailability. These are rat measurements, with no human SC conversion. Awosemo et al. — rat 5-AMQ pharmacokinetics (Animal context · Accessed 2026-09-30)

Source context — Experience with 5-Amino-1MQ after a month: Unverified products; diet/training and mixed routes. Thread includes seller promotion. The blend ratio basis is unstated.

Source context — 5 amino 1mq experiment.: OP injection amount conflicts with its preparation arithmetic; no corrected amount inferred. Pre-existing gut issues and stacks; subjective fat/muscle claims.

Source context — Injectable 5-Amino-1MQ Update! Day 3!: OP contains an affiliate code and ephedrine/SLU-PP-332/MOTS-c co-use. Short follow-up; perceived route equivalence is not PK.

Source context — 5 amino 1mq: Multi-agent self-report, including Reta, NAD, SS-31, BPC157, Testagen and GHKCu; no isolated duration.

Source context — Looking for real-world experiences and data on 5-Amino-1MQ: Unverified products; route/dose frequency gaps, Reta/Tirz/SS-31/Glow co-use; no salt superiority test.

Source context — 5-Amino-1MQ — Full Breakdown: Explicit affiliate promotion. No human SC measurements supplied; clearance/route superiority claims unsupported.

Source context — Awosemo et al. — rat 5-AMQ pharmacokinetics: Rats; abstract only. Doses/salt not specified there; no human SC kinetics.

Eight to twelve weeks on; breaks vary. Circulating charts describe 8–12-week blocks, shorter 4–6-week experiments, and breaks of 2–4, 4–6 or 4–8 weeks. Claims that a break “resets NNMT” are unverified. Continuous cuts, plateau pulses and seasonal reruns also appear. 5-Amino-1MQ guide. (Community guide · Accessed 2026-09-30)

Personal schedules differ from copied tables. One SC commenter describes 2 mg per administration, five days/week, one month on and one week off. Neither this nor a copied table establishes a safe cycling schedule. 5 amino 1mq experiment. (Community discussion · Accessed 2026-09-30)

Blend account: 4–6 weeks on, 2–4 off. The 5-amino/NADH user gives this pattern; it is one person’s practice, not evidence about NNMT reset or long-term safety. Experience with 5-Amino-1MQ after a month (Personal report · Accessed 2026-09-30)

Source context — 5-Amino-1MQ guide.: Guide combines community claims and rodent scaling. Prevalence, diminishing returns and promised timelines are unsupported. Recipes and purchasing links excluded.

Source context — 5 amino 1mq experiment.: OP injection amount conflicts with its preparation arithmetic; no corrected amount inferred. Pre-existing gut issues and stacks; subjective fat/muscle claims.

Source context — Experience with 5-Amino-1MQ after a month: Unverified products; diet/training and mixed routes. Thread includes seller promotion. The blend ratio basis is unstated.

Stacks make favorable stories difficult to interpret. GLP-1s, MOTS-c, NAD-related products and SS-31 recur. Preserved blog examples pair MOTS-c 5–10 mg/week SC with 100 mg oral 5-Amino-1MQ, or tesofensine 0.5 mg/day with 100 mg/day; NMN/NR amounts of 250–500 mg/day also circulate. These are separate untested combinations. Looking for real-world experiences and data on 5-Amino-1MQ (Community discussion · Accessed 2026-09-30)

Concurrent training and diet: Favorable accounts also describe progressive lifting, high protein intake, a measured calorie deficit and tracking steps. Those changes complicate attribution to the compound. [community]

Stack caution: Concurrent agents make before/after attribution impossible; no systematic interaction trials with GLP-1s, MOTS-c, tesofensine, or NAD precursors. [community]

Blend: 5:4 5-amino/NADH; about 15 mg 5-amino. One reply states these particulars but leaves the ratio basis and measured NADH amount unstated. It does not describe 15 mg total blend. Experience with 5-Amino-1MQ after a month (Personal report · Accessed 2026-09-30)

Source context — Looking for real-world experiences and data on 5-Amino-1MQ: Unverified products; route/dose frequency gaps, Reta/Tirz/SS-31/Glow co-use; no salt superiority test.

Source context — Experience with 5-Amino-1MQ after a month: Unverified products; diet/training and mixed routes. Thread includes seller promotion. The blend ratio basis is unstated.

Gut, mood and sleep tradeoffs. Reports include cramps, nausea/loose stool, headache, fatigue, sleep disruption, warmth and higher resting heart rate. A stronger sensation is not evidence of more fat loss. 5 amino 1mq experiment. (Community discussion · Accessed 2026-09-30)

Gut tolerability differs even within one thread. One oral user described cramps at 25 mg twice daily; another reported no cramps at 150 mg/day. A third described severe stomach trouble with both routes. Those differences do not support “injections avoid GI effects.” 5 amino 1mq experiment. (Community discussion · Accessed 2026-09-30)

Muted mood in one oral account. The month-log describes blunted emotions around week three, with diet fatigue also considered. Experience with 5-Amino-1MQ after a month (Personal report · Accessed 2026-09-30)

Product identity and units matter. One oral 50 mg account describes heavy urination and pelvic tension recurring on retry; the writer questioned authenticity and planned testing. No assay result was inspected. Injection sting, redness and orange staining also appear; color or a seller’s test claim cannot establish identity or sterility. My experience with 5amino 1mq (Personal report · Accessed 2026-09-30)

Long-term safety and interactions remain uncertain. Short animal work and reassuring posts cannot establish chronic human safety. Preserved caution discussions raise methylation, liver and cancer questions, and uncertainty in pregnancy/children or medication combinations; these are gaps/theories, not demonstrated clinical harms.

Source quality: Mislabeling enzyme vs inhibitor, wrong dose unit (mg vs mcg), weak or fake COAs, salt-form ambiguity. [community]

Source context — 5 amino 1mq experiment.: OP injection amount conflicts with its preparation arithmetic; no corrected amount inferred. Pre-existing gut issues and stacks; subjective fat/muscle claims.

Source context — Experience with 5-Amino-1MQ after a month: Unverified products; diet/training and mixed routes. Thread includes seller promotion. The blend ratio basis is unstated.

Source context — My experience with 5amino 1mq: Authenticity disputed by OP; no completed assay result inspected. Cross-post duplicates are one account.